2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways
- PMID: 29203195
- DOI: 10.1016/j.jacc.2017.09.1085
2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways
Keywords: ACC Expert Consensus Decision Pathway; atrial fibrillation; deep vein thrombosis; factor II; factor X; gastrointestinal bleeding; intracranial hemorrhage; vitamin K.
Similar articles
-
2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee.J Am Coll Cardiol. 2020 Aug 4;76(5):594-622. doi: 10.1016/j.jacc.2020.04.053. Epub 2020 Jul 14. J Am Coll Cardiol. 2020. PMID: 32680646 No abstract available.
-
A Narrative Review for Perioperative Physicians of the 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants.J Cardiothorac Vasc Anesth. 2019 Feb;33(2):290-301. doi: 10.1053/j.jvca.2018.07.023. Epub 2018 Jul 20. J Cardiothorac Vasc Anesth. 2019. PMID: 30146466 Review.
-
Expert Consensus Decision Pathway of the American College of Cardiology on Management of Bleeding in Patients With Oral Anticoagulants: A Review of the 2020 Update for Perioperative Physicians.J Cardiothorac Vasc Anesth. 2021 Aug;35(8):2471-2479. doi: 10.1053/j.jvca.2021.02.024. Epub 2021 Feb 12. J Cardiothorac Vasc Anesth. 2021. PMID: 33726942 Review.
-
Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).Am J Cardiol. 2017 May 15;119(10):1590-1595. doi: 10.1016/j.amjcard.2017.02.015. Epub 2017 Mar 28. Am J Cardiol. 2017. PMID: 28363354 Clinical Trial.
-
2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.J Am Coll Cardiol. 2017 Nov 7;70(19):2421-2449. doi: 10.1016/j.jacc.2017.09.019. Epub 2017 Oct 18. J Am Coll Cardiol. 2017. PMID: 29055505 Review.
Cited by
-
The Incidence of Thrombotic Events After the Concomitant Use of Andexanet alfa and 4-Factor Prothrombin Complex Concentrate.Hosp Pharm. 2024 Oct;59(5):536-543. doi: 10.1177/00185787241242759. Epub 2024 Mar 29. Hosp Pharm. 2024. PMID: 39318740
-
Vitamin K Antagonist Reversal for Urgent Surgery Using 4-Factor Prothrombin Complex Concentrates: A Randomized Clinical Trial.JAMA Netw Open. 2024 Aug 1;7(8):e2424758. doi: 10.1001/jamanetworkopen.2024.24758. JAMA Netw Open. 2024. PMID: 39088218 Free PMC article. Clinical Trial.
-
Rivaroxaban vs Vitamin K Antagonist in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease.JACC Adv. 2024 Jan 5;3(2):100813. doi: 10.1016/j.jacadv.2023.100813. eCollection 2024 Feb. JACC Adv. 2024. PMID: 38939389 Free PMC article.
-
Acute upper and lower gastrointestinal bleeding management in older people taking or not taking anticoagulants: a literature review.Front Med (Lausanne). 2024 May 3;11:1399429. doi: 10.3389/fmed.2024.1399429. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38765253 Free PMC article. Review.
-
Spontaneous Bleeding in Vestibular Schwannoma in Patients on Oral Anticoagulant Therapy: Report of Two Cases and Review of Literature.Acta Med Acad. 2024 Apr;53(1):90-101. doi: 10.5644/ama2006-124.426. Acta Med Acad. 2024. PMID: 38415661 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
